In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe continue their conversation with Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. They discuss the challenges and opportunities presented by new technologies, particularly in drug development and patient engagement. The conversation highlights the evolution of pharmaceuticals, and the potential of virtual clinical trials. In this conversation, Nathan Teuscher discusses the importance of optimizing drug dosages in oncology, the challenges faced in cell therapy, and the complexities of treating immunocompromised patients. He emphasizes the need for collaboration in the scientific community and shares his perspective on measuring success in life and career. Additionally, Nathan talks about his podcast, Clinical Pharmacology (https://creators.spotify.com/pod/show/clinical-pharmacology), which aims to educate listeners on clinical pharmacology and related topics.
Chapters
00:51 The Changing Landscape of Pharmaceuticals
03:49 Virtual Clinical Trials and Patient Engagement
08:06 Optimizing Drug Dosage in Oncology
10:55 New News! - FDA Approvals (Mesoblast) and Challenges in Cell Therapy
14:26 The Complexities of Cell Therapy
17:33 Navigating Immunocompromised States in Treatment
20:09 Advice to Young Scientists in Biopharma
23:04 Defining Success in Life and Career
24:47 The Purpose and Impact of Nathan's Podcast, Clinical Pharmacology
HOW TO REACH US:
Nathan Teuscher
https://www.linkedin.com/in/nathanteuscher/
Aplos Analytics - https://aplosanalytics.com/
Email: [email protected]
Nathan Teuscher’s Podcast: Clinical Pharmacology Podcast
https://teuschersolutions.com/
Collaboration with BioTalk Unzipped (Ep. 40)
https://podcasts.apple.com/us/podcast/collaboration-with-biotalk-unzipped-ep-40/id1695617234?i=1000682122951
Podcast (on Spotify): https://creators.spotify.com/pod/show/clinical-pharmacology
Podcast (on Apple): https://podcasts.apple.com/us/podcast/clinical-pharmacology-podcast-with-nathan-teuscher/id1695617234
Dr. Chad Briscoe
https://www.linkedin.com/in/chadbriscoe/
Celerion - https://www.celerion.com/
Gregory Austin
https://www.linkedin.com/in/gregoryaustin1/
ECI - https://eci-rx.com /
Takeaways
Nathan Teuscher has over 20 years of experience in clinical pharmacology and pharmacometrics.
Virtual clinical trials can enhance patient engagement and diversity in research.
Finding the right dosage is a critical challenge in drug development.
Project Optimus aims to redefine oncology drug development practices.
AI and data analysis can help identify ideal candidates for clinical trials.
Ethical considerations are paramount in the use of patient data for research. The right dose for each patient varies significantly.
Understanding individual immune system capacities is crucial in treatment.
Collaboration is key to success in the scientific community.
Success is measured by the happiness of loved ones.
Finding joy in helping others is essential for career fulfillment.
Podcasts serve as valuable educational resources.
Engaging with diverse disciplines enhances scientific understanding.
Sound Bites
“If you want to be successful, seek first to understand, then be understood.”
“If you’re looking to help people and in collaboration, you’ll be successful.”
“Success in life is the happiness of loved ones around you.”
New News Story:
After two rejections, FDA approves Mesoblast's first-of-its-kind cell therapy
https://www.fiercepharma.com/pharma/fda-nod-gvhd-cell-therapy-gives-australian-biotech-mesoblast
keywords
BioTalk, pharmacology, AI in pharma, drug development, Nathan Teuscher, pharmacometrics, virtual clinical trials, clinical research, pharmaceuticals, virtual trials, healthcare innovation, drug development, patient engagement, medical technology, drug dosage, oncology, FDA approval, cell therapy, immunocompromised, collaboration, success, clinical pharmacology, podcast, healthcare
